Icosavax, Inc.

Ownership Transactions Reported by 21 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
1930 Boren Ave., Suite 1000, Seattle, Washington

Insiders trading volume in the past year

Icosavax, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Qiming U.S. Healthcare Fund II, L.P. Former 10% Owner $55.2M Aug 2, 2021
Sanofi 10%+ Owner $49.4M Aug 2, 2021
NanoDimension III, L.P. Former 10% Owner $45.2M Aug 2, 2021
Tadataka Yamada Director $11.8M Jul 28, 2021
Cormorant Asset Management, LP Former 10% Owner $6.68M Aug 2, 2021
Douglas Holtzman Chief Scientific Officer $4.59M Jul 3, 2023
Adams Street Partners Llc Former 10% Owner $4.02M Aug 2, 2021
Terry P. Gould Director $4.02M Aug 2, 2021
Charles E. Richardson SVP, Technical Operations $2.59M Jul 29, 2022
Elizabeth Bekiroglu General Counsel & Corp. Sec. $1.61M Feb 15, 2023
Cassia Cearley Former Chief Business Officer $0 -$263K -100% Feb 19, 2024
Mark Mcdade Former Director $0 Feb 19, 2024
Heidi Fields Former Director $0 Feb 19, 2024
Ann M. Veneman Former Director $0 Feb 19, 2024
John W. Shiver Former Director $0 Feb 19, 2024
Jim Wassil Former Director $0 Feb 19, 2024
Adam K. Simpson Former Director and Chief Executive Officer $0 -$2.82M -100% Feb 19, 2024
Niranjan Kanesa-thasan Former Chief Medical Officer $0 -$184K -100% Feb 19, 2024
Ra Capital Management, L.P. Director, 10%+ Owner $0 Feb 19, 2024
Thomas Russo Former Chief Financial Officer $0 -$235K -100% Feb 19, 2024
Amin Khan Former EVP, Head of Research and Development Feb 19, 2024

Recent Insider Transactions by Companies or Individuals for Icosavax, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.